141080 — Legochem Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Market Cap
KR₩2tn
Enterprise Value
KR₩2tn
Revenue
KR₩34bn

Annual balance sheet for Legochem Biosciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	42,205	51,238	60,442	62,391	45,649
Net Total Accounts Receivable
Net Total Receivables	57,181	32,139	157,027	116,391	68,334
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	111,419	100,011	228,951	191,619	134,619
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12,144	7,618	24,432	26,492	25,424
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	141,477	135,912	293,233	252,530	189,502
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15,424	14,009	17,018	28,603	37,072
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	27,728	23,786	34,459	32,932	41,281
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	113,749	112,126	258,775	219,599	148,221
Total Liabilities & Shareholders' Equity	141,477	135,912	293,233	252,530	189,502
Total Common Shares Outstanding
Total Preferred Shares Outstanding